Midterm results of low-dose intravitreal triamcinolone as adjunctive treatment for proliferative XXXX .

@entity1 @entity2995 @entity1715
PURPOSE: To evaluate the midterm anatomical and functional outcomes of intravitreal injection of low-dose @entity2995 in silicone oil-filled eyes as an adjunctive treatment for proliferative @entity1715 . METHODS: This is a retrospective interventional case series. @entity1 with proliferative @entity1715 grade C or D received pars plana vitrectomy combined with silicone oil tamponade and intravitreal injection of 2 mg of @entity2995 in the first stage and silicone oil removal in the second stage. Primary outcome measures were retinal reattachment rate and best-corrected visual acuity. RESULTS: In all, 37 eyes from 37 @entity1 were included in this study. The mean follow-up duration was 22.9    9.6 months. Retina was reattached in 36 (97.3%) eyes at the last visit. The mean best-corrected visual acuity was 1.76    0.56 logMAR at baseline, which improved to 0.87    0.60 logMAR at the last visit (P < 0.001). Best-corrected visual acuity increased in 31 (83.8%) eyes, remained unchanged in 5 (13.5%) eyes, and decreased in 1 (2.7%) eye at last visit compared with baseline. CONCLUSION: Low-dose (2 mg) @entity2995 intravitreal injection as an adjunct to vitrectomy and silicone oil tamponade in treating proliferative @entity1715 (grade C or D) appears to be effective and safe.
